Impacts of NF1 Gene Mutations and Genetic Modifiers in Neurofibromatosis Type 1
Authors:
- Wei WangWWWei Wang
- Cheng-Jiang WeiCWCheng-Jiang Wei
- Xi-Wei CuiXCXi-Wei Cui
- Qing-Feng LiQLQing-Feng Li
- Zhi-Chao WangZWZhi-Chao Wang
Open Access
- 8 September 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 12
Abstract
Neurofibromatosis type 1 (NF1) is a tumor predisposition genetic disorder that directly affects more than 1 in 3,000 individuals worldwide. It results from mutations of the NF1 gene and shows almost complete penetrance. NF1 patients show high phenotypic variabilities, including cafe-au-lait macules, freckling, or other neoplastic or non-neoplastic features. Understanding the underlying mechanisms of the diversities of clinical symptoms might contribute to the development of personalized healthcare for NF1 patients. Currently, studies have shown that the different types of mutations in the NF1 gene might correlate with this phenomenon. In addition, genetic modifiers are responsible for the different clinical features. In this review, we summarize different genetic mutations of the NF1 gene and related genetic modifiers. More importantly, we focus on the genotype–phenotype correlation. This review suggests a novel aspect to explain the underlying mechanisms of phenotypic heterogeneity of NF1 and provides suggestions for possible novel therapeutic targets to prevent or delay the onset and development of different manifestations of NF1.Keywords
This publication has 124 references indexed in Scilit:
- Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1Neuro-Oncology, 2012
- Pediatric Plexiform Neurofibromas: Impact on Morbidity and Mortality in Neurofibromatosis Type 1The Journal of Pediatrics, 2012
- Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type IHuman Molecular Genetics, 2011
- Neurofibromin (Nf1) is required for skeletal muscle developmentHuman Molecular Genetics, 2011
- Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotypeAmerican Journal of Hematology, 2011
- The Development of Cutaneous NeurofibromasThe American Journal of Pathology, 2011
- Tumor microenvironment and neurofibromatosis type I: connecting the GAPsOncogene, 2007
- An Absence of Cutaneous Neurofibromas Associated with a 3-bp Inframe Deletion in Exon 17 of the NF1 Gene (c.2970-2972 delAAT): Evidence of a Clinically Significant NF1 Genotype-Phenotype CorrelationThe American Journal of Human Genetics, 2007
- ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiaeCell Metabolism, 2006
- Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1Journal of Medical Genetics, 2006